Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2020 Filed Sep 23, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $31.71 | $120,638.29 |
DisclosureSEC source: 0001209191-20-051679 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 22, 2020 Filed Sep 23, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-051679 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · derivative · entry 8 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,444 Underlying: Common Stock · 2,315 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 465 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · derivative · entry 7 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,646 Underlying: Common Stock · 465 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 9,720 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · derivative · entry 6 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,242 Underlying: Common Stock · 9,720 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $31.92 | $159,591.00 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · nonDerivative · entry 5 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $31.88 | $239,103.00 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · nonDerivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 2,315 | $5.18 | $11,980.13 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 465 | $1.53 | $711.45 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 9,720 | $1.58 | $15,309.00 |
DisclosureSEC source: 0001209191-20-051170 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:30 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-049970 · doc4.xml · derivative · entry 4 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,890 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:30 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 2,340 | $29.98 | $70,147.58 |
DisclosureSEC source: 0001209191-20-049970 · doc4.xml · nonDerivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:30 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,465 | $30.00 | $43,950.00 |
DisclosureSEC source: 0001209191-20-049970 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,340 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:30 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-049970 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 20:23 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-049397 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,962 Underlying: Common Stock · 12,500 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 20:23 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $32.91 | $164,537.00 |
DisclosureSEC source: 0001209191-20-049397 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 20:23 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $32.88 | $246,621.75 |
DisclosureSEC source: 0001209191-20-049397 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 20:23 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 12,500 | $1.58 | $19,687.50 |
DisclosureSEC source: 0001209191-20-049397 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:22 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,943 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-049394 · doc4.xml · derivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,241 Underlying: Common Stock · 6,943 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:22 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 6,943 | $39.15 | $271,796.23 |
DisclosureSEC source: 0001209191-20-049394 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:22 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 6,943 | $1.58 | $10,935.23 |
DisclosureSEC source: 0001209191-20-049394 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 22:52 UTC |
Napolitano JanetDirector
|
GrantStock Option (Right to Buy) · Derivative | 33,000 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001209191-20-048972 · doc4.xml · derivative · entry 1 Napolitano Janet · CIK 0001821008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2030-08-28 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on August 28, 2021, and the remaining shares vest in 24 equal monthly installments thereafter. Read SEC document |
| August 25, 2020 Filed Sep 10, 2020 20:29 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,560 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-049967 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,695 Underlying: Common Stock · 25,560 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 25, 2020 Filed Sep 10, 2020 20:29 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 5,560 | $42.92 | $238,632.42 |
DisclosureSEC source: 0001209191-20-049967 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.8999 to $42.9611, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| August 25, 2020 Filed Sep 10, 2020 20:29 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 25,560 | $1.53 | $39,106.80 |
DisclosureSEC source: 0001209191-20-049967 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · derivative · entry 8 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,333 Underlying: Common Stock · 14,000 shares Expires 2027-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · derivative · entry 7 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,759 Underlying: Common Stock · 2,315 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. F4 · balance_after: The total number of shares remaining under this stock option has been adjusted by 50 shares to correct a typographical error that occurred in the reporting person's Form 4 filed July 2, 2020. The total number of shares remaining under this stock option following the transaction reported on July 2, 2020 was underreported by 50 shares. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,185 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · derivative · entry 6 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,462 Underlying: Common Stock · 10,185 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $50.94 | $382,047.75 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · nonDerivative · entry 5 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $50.96 | $254,807.50 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · nonDerivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,277 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 14,000 | $0.86 | $11,970.00 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 2,315 | $5.18 | $11,980.13 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:39 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 10,185 | $1.58 | $16,041.38 |
DisclosureSEC source: 0001209191-20-047942 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-046369 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,255 Underlying: Common Stock · 7,900 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 7,900 | $51.08 | $403,562.81 |
DisclosureSEC source: 0001209191-20-046369 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.0414 to $51.1593, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 7,900 | $1.53 | $12,087.00 |
DisclosureSEC source: 0001209191-20-046369 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 21:07 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-045688 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,647 Underlying: Common Stock · 12,500 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 21:07 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $50.89 | $381,695.25 |
DisclosureSEC source: 0001209191-20-045688 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 21:07 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $50.91 | $254,526.50 |
DisclosureSEC source: 0001209191-20-045688 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 21:07 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 12,500 | $1.58 | $19,687.50 |
DisclosureSEC source: 0001209191-20-045688 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 21:14 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,851 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-044748 · doc4.xml · derivative · entry 5 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,184 Underlying: Common Stock · 1,851 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 21:14 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,259 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-20-044748 · doc4.xml · derivative · entry 4 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,037 Underlying: Common Stock · 9,259 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 21:14 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 11,110 | $47.65 | $529,403.72 |
DisclosureSEC source: 0001209191-20-044748 · doc4.xml · nonDerivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 21:14 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 1,851 | $1.58 | $2,915.33 |
DisclosureSEC source: 0001209191-20-044748 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 21:14 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 9,259 | $1.49 | $13,749.62 |
DisclosureSEC source: 0001209191-20-044748 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 21:45 UTC |
Rice Steven J.Chief Administrative Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $47.06 | $0.00 |
DisclosureSEC source: 0001209191-20-044534 · doc4.xml · derivative · entry 1 Rice Steven J. · CIK 0001820108 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-07-30 F1 · derivative.exercise_date: 1/4 of the shares subject to the stock option vest and become exercisable on July 30, 2021, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 23:03 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-044060 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508,155 Underlying: Common Stock · 7,900 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 23:03 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 7,900 | $47.99 | $379,090.19 |
DisclosureSEC source: 0001209191-20-044060 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.9679 to $48.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 23:03 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 7,900 | $1.53 | $12,087.00 |
DisclosureSEC source: 0001209191-20-044060 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $49.52 | $371,435.25 |
DisclosureSEC source: 0001209191-20-042652 · doc4.xml · nonDerivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.